|1.||Priyanka, N: 3 articles (07/2015 - 04/2013)|
|2.||Kalra, Nitish: 3 articles (07/2015 - 04/2013)|
|3.||Pradeep, A R: 3 articles (07/2015 - 04/2013)|
|4.||Malgaonkar, Nikhil: 2 articles (07/2015 - 04/2015)|
|5.||Saquib, Shahab: 2 articles (07/2015 - 04/2015)|
|6.||Kudyar, Nitin: 1 article (07/2015)|
|7.||Jain, Hunny: 1 article (07/2015)|
|8.||Saquib, Shahabe: 1 article (04/2015)|
|9.||Varsha, Jadhav: 1 article (04/2015)|
|10.||Tarakji, Bassel: 1 article (04/2015)|
07/01/2015 - "Clinical and microbiological efficacy of 3% satranidazole gel as a local drug delivery system in the treatment of chronic periodontitis: A randomized, controlled clinical trial."
04/01/2015 - "Efficacy of Subgingivally Delivered Satranidazole in the Treatment of Type 2 Diabetes Subjects with Chronic Periodontitis: A Randomized Controlled Clinical Trial."
04/01/2013 - "A randomized controlled clinical trial on the clinical and microbiological efficacy of systemic satranidazole in the treatment of chronic periodontitis."
07/01/2015 - "The present clinical trial was designed to investigate the effectiveness of subgingivally delivered satranidazole (SZ) gel as an adjunct to scaling and root planing (SRP) in the treatment of chronic periodontitis. "
04/01/2015 - "The present clinical trial was designed to investigate the effectiveness of subgingivally delivered satranidazole (SZ) gel as an adjunct to scaling and root planing (SRP) in the treatment of chronic periodontitis. "
01/01/2009 - "This study confirmed the acceptability and effectiveness of satranidazole gel for treatment of periodontitis."
01/01/2009 - "The aim of the paper was to develop satranidazole-containing mucoadhesive gel for the treatment of periodontitis. "
01/01/2009 - "Development of satranidazole mucoadhesive gel for the treatment of periodontitis."
|4.||Amebic Liver Abscess
12/01/2006 - "The aims of our randomized, single-blind trial involving 49 patients were to study the efficacy, side effects, and tolerance of metronidazole and satranidazole in patients of amebic liver abscess. "
12/01/2006 - "Randomized, single-blind, placebo-controlled multicenter trial to compare the efficacy and safety of metronidazole and satranidazole in patients with amebic liver abscess."
09/01/1993 - "These data suggest that higher plasma and liver concentrations of satranidazole and greater intrinsic potency probably contribute to superior amoebicidal activity in the hamster model of hepatic infection."
04/01/1985 - "Satranidazole: experimental evaluation of activity against anaerobic bacteria in vitro and in animal models of anaerobic infection."
11/01/1983 - "Go.10213, a novel nitroimidazole, may prove to be the most potent and safe agent against the protozoal infections, e.g. "
03/01/1992 - "Nitroimidazoles, Part XXIII--activity of satranidazole series against anaerobic infections."
04/01/1991 - "Four of the 5-nitroimidazoles tested (satranidazole, S75 0400 A, flunidazole and ronidazole) were found to be more active than metronidazole, the drug commonly used to treat infections caused by B. "
|7.||Dihydrotachysterol (AT 10)